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Kaposi sarcoma (KS) is an angiogenic, inflam-
matory  neoplasm  first  described  by  Moritz   
Kaposi (1872). The etiology of KS was un-
known until Chang et al. (1994) isolated KS-
associated herpesvirus, also known as human 
herpesvirus (HHV)-8, from KS lesions. Cells of 
endothelial origin are the principal targets of 
HHV-8 infection and the major components 
proliferating in KS lesions (Ganem, 2010). It 
has been clearly established that all forms of KS 
are associated with HHV-8 (Dupin et al., 1995; 
Moore and Chang, 1995; Schalling et al., 1995; 
Chang et al., 1996). Infection with HHV-8 is 
necessary but not sufficient for the develop-
ment of KS. Despite the high seroprevalence of 
HHV-8, at up to 30% in the Mediterranean 
Basin (classic KS) and 70% in sub-Saharan Africa 
(endemic KS), the incidence of KS is very low 
(Boshoff and Weiss, 2001). Individuals with   
acquired immunodeficiency caused by HIV   
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Classic Kaposi sarcoma (KS) is exceedingly rare in children from the Mediterranean Basin, 
despite the high prevalence of human herpesvirus-8 (HHV-8) infection in this region.  
We hypothesized that rare single-gene inborn errors of immunity to HHV-8 may underlie 
classic KS in childhood. We investigated a child with no other unusually severe infectious 
or tumoral phenotype who died from disseminated KS at two years of age. Whole-exome 
sequencing in the patient revealed a homozygous splice-site mutation in STIM1, the gene 
encoding stromal interaction molecule 1, which regulates store-operated Ca2+ entry. STIM1 
mRNA splicing, protein production, and Ca2+ influx were completely abolished in EBV-
transformed B cell lines from the patient, but were rescued by the expression of wild-type 
STIM1. Based on the previous discovery of STIM1 deficiency in a single family with a severe 
T cell immunodeficiency and the much higher risk of KS in individuals with acquired T cell 
deficiencies, we conclude that STIM1 T cell deficiency precipitated the development of 
lethal KS in this child upon infection with HHV-8. Our report provides the first evidence 
that isolated classic KS in childhood may result from single-gene defects and provides 
proof-of-principle that whole-exome sequencing in single patients can decipher the  
genetic basis of rare inborn errors.
© 2010 Byun et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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pulmonary lesions 4 mo later. She had no history of other se-
vere infections or tumors, but presented autoimmune hemo-
lytic anemia. The counts and proportions of blood T, B, and 
NK cells and subsets were normal, as were serum immuno-
globulin levels. T cell responses to mitogens and antigens 
were not tested. Serologic tests for HIV were negative, and 
KS was diagnosed on the basis of skin biopsies demonstrating 
the presence of spindle cells and positive staining for HHV-8 
in situ. Our investigations of the genetic basis of KS in this 
child did not begin until after she had died.
We hypothesized that this child might have carried a 
homozygous mutation in a gene important for immunity to 
HHV-8, given the consanguinity of her parents. We searched 
for candidate mutations by massive parallel sequencing of the 
patient’s exome (Table I). Identified substitutions and inser-
tions/deletions (indels) were screened with the following cri-
teria: (a) not found in dbSNP 129, 1000 genomes, or in-house 
database (composed of 49 exomes); (b) predicted to have one 
of the following functional impacts: nonsense, missense, splice-
site mutations, or coding indels; (c) homozygous. 1 splice-site 
mutation and 11 missense mutations fulfilled all these criteria. 
The splice-site mutation was at a consensus splice acceptor 
site in STIM1, which was retained as a strong candidate gene 
for predisposition to KS, based on the recent description of a 
family with autosomal recessive STIM1 deficiency and pri-
mary T cell immunodeficiency (Picard et al., 2009). In con-
trast, none of the 11 genes carrying missense mutations were 
clearly implicated in immunity or selectively expressed in 
endothelial cells (Table S1). We confirmed the variation in 
STIM1, a G to A substitution at the 1 position of 5-exon 
8 (1,538–1G>A), by Sanger sequencing (Fig. 1 A). This vari-
ation was not found in 100 healthy Turkish control subjects 
(total of 200 chromosomes), suggesting that it is not an ir-
relevant polymorphism and may be a rare allele conferring 
predisposition to KS. No additional unreported variation in 
infection (epidemic KS; Martellotta et al., 2009) or immuno-
suppression after organ transplantation (iatrogenic KS; Lebbé 
et al., 2008) are at a much higher risk of developing KS than 
the  general  population.  Host  factors  in  other  patients  are 
therefore likely to play a critical role in determining the out-
come of HHV-8 infection, including the development of KS 
in particular.
As a first approach to testing the hypothesis that KS may 
result from inborn errors of immunity to HHV-8 in some 
patients (Casanova and Abel, 2007), we focused on classic KS 
in childhood. Classic KS is exceedingly rare in children, with 
only 30 cases reported since 1960, and follows a disseminated 
and often lethal course (Dutz and Stout, 1960; Bisceglia et al., 
1988; Akman et al., 1989; Zurrida et al., 1994; Erdem et al., 
1999; Landau et al., 2001; Ferrari et al., 2002; Hussein, 2008). 
We previously reported two children from the Mediterra-
nean Basin with KS caused by an underlying primary immuno-
deficiency, one with autosomal recessive complete IFN-R-1 
deficiency (Camcioglu et al., 2004) and the other with   
X-linked recessive Wiskott-Aldrich syndrome (Picard et al., 
2006). These children had several other clinical phenotypes, 
including mycobacterial disease in the IFN-R1–deficient 
child and EBV-driven lymphoma in the child with Wiskott-
Aldrich syndrome. These two cases provided the first evi-
dence that classic KS in childhood may result from inborn 
errors of immunity, at least in children with multiple infec-
tious and tumoral phenotypes, including KS.
More  recently,  we  described  three  unrelated  Turkish 
children with classic KS in the absence of any other infectious 
or tumoral phenotype, each born to consanguineous parents 
(Sahin et al., 2010). This suggested that classic KS in children 
with no overt signs of immunodeficiency might also result 
from single-gene defects impairing HHV-8 immunity. Because 
the age of onset, clinical features, and outcome of KS reported 
in previous studies differ from child to child (Dutz and Stout, 
1960; Bisceglia et al., 1988; Akman et al., 1989; Zurrida   
et al., 1994; Erdem et al., 1999; Landau et al., 2001; Ferrari 
et al., 2002; Picard et al., 2006; Camcioglu et al., 2004; Hussein, 
2008; Sahin et al., 2010), we further hypothesized that the 
single-gene inborn errors of immunity underlying classic KS 
in children are heterogeneous. We focused our investigation 
on a single Turkish child with early-onset disseminated KS 
that eventually ran a lethal course, using the recently devel-
oped whole-exome sequencing approach, which has been 
used to determine the genetic basis of other rare Mendelian 
disorders in small numbers of affected individuals (Choi et al., 
2009; Hoischen et al., 2010; Lalonde et al., 2010; Ng et al., 
2010; Walsh et al., 2010).
RESULTS AND DISCUSSION
The patient was born to consanguineous parents of Turkish 
origin. A detailed case report has been published elsewhere 
(case 1; Sahin et al., 2010). In brief, at 2 yr of age, the patient 
developed a first KS lesion on the lip, which was followed by 
rapid dissemination throughout the body. She had lymph-
adenopathy and hepatosplenomegaly, and she died from severe 
Figure 1.  Identification of a splice-site mutation in STIM1. 
(A) Sanger sequencing of genomic DNA confirmed G to A substitution at 
the 1 position of STIM1 exon 8 (1538-1G>A) in the patient, which was 
initially identified by whole-exome sequencing. Sequencing of genomic 
DNA extracted from EBV-B cells of a healthy control shows the reference 
base G at the same position. (B) STIM1 genotypes of the patient and her 
family members from whom DNA was available for sequence analysis are 
listed under their symbols. Squares, males; circles, females; filled symbol, 
affected individual; open symbols, unaffected individuals; double horizon-
tal line, consanguineous marriage. Genotyping was performed twice.JEM VOL. 207, October 25, 2010  2309
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products were cloned and sequenced. Wild-type transcripts 
were completely lacking from the patient’s cells, which con-
tained only abnormally spliced variants (Fig. 2 B). As expected, 
given  the  absence  of  wild-type  transcripts,  no  wild-type 
STIM1 protein was detected in the patient’s EBV-B cells, 
whereas high levels of wild-type STIM1 protein were found 
in cells from healthy individuals, as shown by Western blot-
ting with two different STIM1-specific antibodies (Fig. 2 C). 
No other protein band corresponding to the translation prod-
ucts of abnormally spliced variants was detected in the patient’s 
EBV-B cells (unpublished data).
The complete lack of protein production detected sug-
gested that STIM1 function would also be severely impaired, 
if not completely abolished. STIM1, an ER-resident trans-
membrane protein, senses the depletion of ER Ca2+ stores 
and activates the calcium release–activated calcium channel 
consisting of ORAI1 in the plasma membrane (Feske, 2009). 
This process is referred to as store-operated Ca2+ entry 
(SOCE). Upon treatment with thapsigargin, an inhibitor of 
the sarco/endoplasmic reticulum Ca2+-ATPase that induces 
Ca2+ depletion in the ER, a small increase in intracellular Ca2+ 
concentration corresponding to the release of Ca2+ from ER 
stores in the absence of extracellular Ca2+ was observed in 
healthy control EBV-B cells (Fig. 3 A). This small increase was 
followed by a larger, sustained influx of Ca2+ upon readdition 
of extracellular Ca2+. In contrast, the influx of extracellular 
Ca2+ was completely abolished in the patient’s EBV-B cells, 
despite normal Ca2+ release from the ER stores (Fig. 3 A). The 
retrovirus-mediated production of wild-type STIM1 restored 
SOCE in the patient’s cells, demonstrating that STIM1 defi-
ciency was indeed the cause of impaired SOCE (Fig. 3 B). 
Thus, the child had complete STIM1 deficiency, caused by the 
inheritance of a homozygous loss-of-function STIM1 allele. 
STIM1 coding sequences and essential splice sites (1 and 
2 positions) was found in the patient. The familial segrega-
tion of the mutant STIM1 allele was consistent with an auto-
somal recessive trait (Fig. 1 B).
We investigated the impact of this mutation on the bio-
synthesis and function of the STIM1 protein by studying 
EBV-transformed B cells (EBV-B cells) from the patient. No 
other material was available from the deceased patient. Quan-
titative RT-PCR demonstrated that levels of STIM1 mRNA 
were lower (30%) in the patient’s cells than in healthy control 
cells (Fig. 2 A). We investigated a possible impairment of the 
splicing of exon 8 in the patient’s cells, by amplifying cDNA 
fragments corresponding to exons 7–9 of STIM1 from the 
EBV-B cells of healthy controls and the patient. The PCR 
Table I.  Summary statistics for exome sequencing
Reads/variants No.
Total number of reads 30,054,578
Uniquely mapped reads 13,267,598
Total variants called 20,108
Substitutions
  Total (novela) 18,891 (1,416)
  Synonymous (novela) 3,270 (169)
  Nonsense (novela) 19 (4)
  Missense (novela) 2,718 (414)
  Splice-site (novela) 8 (4)
Indels 1,217
dbSNP rateb 92.50%
dbSNP concordanceb 99.68%
aNumber of variants not found in dbSNP129 and 1000 genomes.
bdbSNP rate and concordance are based on dbSNP129.
Figure 2.  Abnormal STIM1 mRNA splicing and lack 
of protein expression in the patient’s EBV-B cells.  
(A) Levels of STIM1 mRNA were assessed by quantitative 
RT-PCR in the EBV-B cells from five healthy controls  
(C) and the patient (P). Threshold cycles (CT) for STIM1, 
normalized to those of GUS (CT), are plotted as 2(CT). 
Each dot or square represents a mean of three indepen-
dent experiments for each individual. The horizontal bar 
indicates the mean of five healthy controls. (B) STIM1 
exons 7–9 were amplified from cDNA from EBV-B cells of 
the control (C) or the patient (P) and ligated to pCR2.1 
vector. Clones containing STIM1 transcripts were se-
quenced, and the frequency of each splice variant was 
calculated by dividing the number of clones containing 
the particular transcript by the total number of se-
quenced clones (n = 12 for C, n = 120 for P). 16/120 of P 
clones corresponded to other minor abnormal transcript 
forms (not depicted). Number of base pairs indicated 
between the exons in abnormally spliced variants of the 
patient represents the size of gain or loss, compared with 
the wild-type transcript. (C) Levels of STIM1 protein were assessed by immunoblotting with an antibody against the C terminus (left) or N terminus (right) 
of STIM1. Two fibroblast cell lines, derived from either a healthy individual (C+) or a previously reported STIM1-deficient patient (C; Picard et al., 2009), 
were used as controls. C1, C2, and C3 show EBV-B cells from healthy controls and P shows EBV-B cells from the patients. GAPDH blots show comparable 
protein loading for each sample. Asterisks indicate nonspecific protein bands. Representative blots of three independent experiments are shown.2310 STIM1 deficiency discovered by whole-exome sequencing | Byun et al.
This approach may be particularly useful for deciphering new 
primary immunodeficiencies in children with sporadic, severe 
infections caused by a particular pathogen but without an 
overt immunological phenotype, not only rare phenotypes 
such as KS and herpes simplex encephalitis, but also more 
common infections, such as invasive pneumococcal disease 
and tuberculosis (Casanova and Abel, 2007; Alcaïs et al., 2009). 
Whole-exome sequencing in single patients with almost any 
sporadic phenotypes holds the promise to decipher both rare 
and common inborn errors.
MATERIALS AND METHODS
Massively parallel sequencing. 3 µg DNA extracted from EBV-B cells 
from the patient was sheared with Covaris S2 Ultrasonicator (Covaris). An 
adapter-ligated library was prepared with the Paired-End Sample Prep kit V1 
(Illumina). Exome capture was performed with the SureSelect Human All 
Exon kit (Agilent Technologies). Single-end sequencing was performed on 
an Illumina Genome Analyzer IIx (Illumina), generating 72-base reads.
Sequence alignment, variant calling, and annotation. The sequences 
were aligned with the human genome reference sequence (hg18 build),   
using BWA aligner (Li and Durbin, 2009). Three open-source packages 
were used for downstream processing and variant calling: Genome analysis 
toolkit (GATK; McKenna et al., 2010), SAMtools (Li et al., 2009), and 
Picard Tools. Substitution calls were made with GATK UnifiedGenotyper, 
whereas indel calls were made with GATK IndelGenotyperV2. All calls with 
a read coverage ≤4x and a Phred-scaled SNP quality of ≤30 were filtered out. 
All the variants were annotated with SeattleSeq SNP annotation.
Genomic DNA sequencing. Genomic DNA was isolated from the EBV-
B cells of the patient or the peripheral blood mononuclear cells of the family 
members. The 5-CCTGGGAGAGTTGTAAAGCA-3 and 5-CCCAC-
CACCAGGATATCTC-3 primers were used to sequence STIM1 exon 8 
and its flanking intron regions.
Quantitative RT-PCR. Total RNA from EBV-B cells was used to gener-
ate cDNA with the SuperScript III First-Strand Synthesis System (Invitro-
gen). STIM1 expression was assessed in the TaqMan gene expression assay 
(Hs00963373_m1; Applied Biosystems), with normalization of the results as 
a function of GUS (-glucuronidase) gene expression.
This finding is consistent with the similarity between this 
patient and the previously reported STIM1-deficient patients, 
who displayed severe opportunistic infection and autoimmunity 
(Picard et al., 2009). The other, previously reported STIM1-
deficient patients displayed muscular hypotonia, partial iris 
hypoplasia, and dental enamel effects, which would probably 
not have been picked up in our patient because of the early 
onset and fatal outcome of KS.
We identified STIM1 deficiency as the first genetic etiol-
ogy of isolated classic KS in childhood. The identification of 
STIM1 deficiency as the cause of severe KS in this child was 
based on the following evidence: (a) the patient presented 
autosomal recessive, complete STIM1 deficiency; (b) STIM1 
deficiency has been reported to cause profound T cell defi-
ciency in another sibship (Picard et al., 2009); (c) acquired T cell 
deficiencies are known risk factors for the development of 
KS; and (d) a genome-wide search for mutations in up to 95% 
of the genes present in the genome (based on National Center 
for Biotechnology Information Consensus Coding Sequence 
Database) failed to identify another plausible candidate muta-
tion in the patient. We have excluded STIM1 deficiency in 
the other two Turkish children with KS who developed the 
disease later (at 9 yr of age), responded to treatment, and have 
remained well (Sahin et al., 2010; unpublished data). The 
whole-exome investigation of these patients would be ex-
pected to reveal other new genetic etiologies of KS, perhaps 
more specific to anti–HHV-8 immunity.
In recent months, whole-exome sequencing has led to 
identification of the molecular basis of rare Mendelian disor-
ders in small numbers (two to four) of unrelated affected in-
dividuals (Hoischen et al., 2010; Lalonde et al., 2010; Ng   
et al., 2010), or in a single affected individual when used in 
conjunction with homozygosity mapping (Choi et al., 2009; 
Walsh et al., 2010). Our study provides the first evidence that 
whole-exome sequencing in a single patient can, without the 
aid of homozygosity mapping, lead to successful identifica-
tion of the genetic basis of rare inborn errors, when com-
bined  with  biochemical  and  cellular  characterization  to 
demonstrate the deleterious effect of the identified mutations. 
Figure 3.  Abolished Ca2+ influx in the patient’s EBV-B 
cells is restored by expression of STIM1. (A) EBV-B cells 
of the patient (P) and two controls (C1 and C2) were stimu-
lated with 1 µM thapsigargin (TG) in Ca2+-free Ringer solu-
tion (open bars) followed by perfusion with 2 mM Ca2+ (filled 
bars) to induce Ca2+ influx. Traces represent mean F340/F380 
emission ratios of one representative experiment. Averages 
on the right are from n = 6 (C1), n = 4 (C2), n = 5 (P) experi-
ments. F340/F380 represents peak [Ca2+]i 25 s after readdi-
tion of Ca2+ minus baseline [Ca2+]i at the beginning of the 
recording. Error bars represent the SEM. ***, P < 0.0001. 
(B) EBV-B cells from the patient were retrovirally transduced 
with STIM1-IRES-GFP expression vector (P-STIM1) or ORAI1-
IRES-GFP vector (P-ORAI1). Ca2+ levels were measured as 
described in A. Traces of individual cells (thin gray lines) and 
averages of all cells (thick black lines) are shown for 90 GFP+ 
and 90 GFP cells. Averages of peak F340/F380 from total 
368 cells (P-STIM1; n = 6 experiments) or 482 cells (P-ORAI1; 
n = 10 experiments) are shown in the bar graph. Error bars 
represent the SEM. ***, P < 0.0001; ns, P > 0.05.JEM VOL. 207, October 25, 2010  2311
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retrovirus by spinoculation onto tissue culture plates coated with 10 µg/ml 
RetroNectin (TaKaRa). Transduction efficiency was assessed by evaluating 
the percentage of GFP+ cells using flow cytometry.
Ca2+ flux measurement. Intracellular Ca2+ levels were measured by time-
lapse single cell Ca2+ imaging, as previously described (Feske et al., 2005).   
In brief, EBV-B cells loaded with 1 µM Fura-2/AM (Invitrogen) were stim-
ulated by passive store depletion with 1 µM thapsigargin (EMD Biosciences) 
in nominally Ca2+-free Ringer’s solution, followed by readdition of Ringer’s 
solution containing 2 mM CaCl2. Ca2+ levels were measured as the ratio of 
the emitted fluorescence at 340 and 380 nm (F340/F380) with an IX81 epi-
fluorescence microscope (Olympus) and Slidebook imaging software v4.2 
(Olympus). We analyzed >60 cells per experiment. For the analysis of intra-
cellular Ca2+ levels in EBV-B cells transduced with retrovirus, we studied at 
least 48 GFP+ and 48 GFP cells on average per experiment in 6–10 experi-
ments per condition in total.
Online supplemental material. Table S1 provides the list of non-reported 
homozygous  variations  in  the  patient  identified  by  whole-exome  se-
quencing. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20101597/DC1.
We thank the patient’s family for their trust, and all members of the laboratory for 
helpful discussions.
The Laboratory of Human Genetics of Infectious Diseases is supported by grants 
from Institut National de la Santé et de la Recherche Médicale, University Paris 
Descartes, The Rockefeller University Center for Clinical and Translational Science 
grant number 5UL1RR024143-03, The Rockefeller University, and St. Giles Foundation. 
S. Feske is supported by National Institutes of Health grant AI066128. M. Byun is 
supported by Cancer Research Institute postdoctoral fellowship, and S. Plancoulaine 
is supported in part by a fellowship from Assistance Publique-Hôpitaux de Paris.
The authors have no conflicting financial interests. S. Feske is a co-founder of 
CalciMedica Inc. and a member of its scientific advisory board.
Submitted: 5 August 2010
Accepted: 14 September 2010
REFERENCES
Akman, E.S., U. Ertem, V. Tankal, A. Pamir, A.M. Tuncer, and O. Uluoglu. 
1989. Aggressive Kaposi’s sarcoma in children: a case report. Turk. J. 
Pediatr. 31:297–303.
Alcaïs, A., L. Abel, and J.L. Casanova. 2009. Human genetics of infec-
tious diseases: between proof of principle and paradigm. J. Clin. Invest. 
119:2506–2514. doi:10.1172/JCI38111
Bisceglia, M., M. Amini, and C. Bosman. 1988. Primary Kaposi’s sarcoma of 
the lymph node in children. Cancer. 61:1715–1718. doi:10.1002/1097-
0142(19880415)61:8<1715::AID-CNCR2820610833>3.0.CO;2-P
Boshoff,  C.,  and  R.A.  Weiss.  2001.  Epidemiology  and  pathogenesis  of 
Kaposi’s sarcoma-associated herpesvirus. Philos. Trans. R. Soc. Lond. B 
Biol. Sci. 356:517–534. doi:10.1098/rstb.2000.07782312 STIM1 deficiency discovered by whole-exome sequencing | Byun et al.
Li, H., and R. Durbin. 2009. Fast and accurate short read alignment with 
Burrows-Wheeler transform. Bioinformatics. 25:1754–1760. doi:10.1093/ 
bioinformatics/btp324
Li, H., B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, 
G. Abecasis, and R. Durbin; 1000 Genome Project Data Processing 
Subgroup. 2009. The Sequence Alignment/Map format and SAMtools. 
Bioinformatics. 25:2078–2079. doi:10.1093/bioinformatics/btp352
Martellotta, F., M. Berretta, E. Vaccher, O. Schioppa, E. Zanet, and U. Tirelli. 
2009. AIDS-related Kaposi’s sarcoma: state of the art and therapeutic strat-
egies. Curr. HIV Res. 7:634–638. doi:10.2174/157016209789973619
McKenna, A.H., M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. 
Kernytsky, K. Garimella, D. Altshuler, S. Gabriel, M. Daly, and M. 
Depristo. 2010. The Genome Analysis Toolkit: A MapReduce frame-
work for analyzing next-generation DNA sequencing data. Genome 
Res. 20:1297–1303.
Moore, P.S., and Y. Chang. 1995. Detection of herpesvirus-like DNA se-
quences in Kaposi’s sarcoma in patients with and without HIV infection. 
N. Engl. J. Med. 332:1181–1185. doi:10.1056/NEJM199505043321801
Ng, S.B., K.J. Buckingham, C. Lee, A.W. Bigham, H.K. Tabor, K.M. 
Dent, C.D. Huff, P.T. Shannon, E.W. Jabs, D.A. Nickerson, et al. 
2010. Exome sequencing identifies the cause of a mendelian disorder. 
Nat. Genet. 42:30–35. doi:10.1038/ng.499
Picard, C., F. Mellouli, R. Duprez, G. Chédeville, B. Neven, S. Fraitag, 
J. Delaunay, F. Le Deist, A. Fischer, S. Blanche, et al. 2006. Kaposi’s 
sarcoma  in  a  child  with  Wiskott-Aldrich  syndrome.  Eur.  J.  Pediatr. 
165:453–457. doi:10.1007/s00431-006-0107-2
Picard, C., C.A. McCarl, A. Papolos, S. Khalil, K. Lüthy, C. Hivroz, 
F.  LeDeist,  F.  Rieux-Laucat,  G.  Rechavi,  A.  Rao,  et  al.  2009. 
STIM1 mutation associated with a syndrome of immunodeficiency 
and autoimmunity. N. Engl. J. Med. 360:1971–1980. doi:10.1056/ 
NEJMoa0900082
Sahin, G., A. Palanduz, G. Aydogan, O. Cassar, A.U. Ertem, L. Telhan, 
N.  Canpolat,  E.  Jouanguy,  C.  Picard,  A.  Gessain,  et  al.  2010. 
Classic  Kaposi  sarcoma  in  3  unrelated  Turkish  children  born  to 
consanguineous  kindreds.  Pediatrics.  125:e704–e708.  doi:10.1542/ 
peds.2009-2224
Schalling, M., M. Ekman, E.E. Kaaya, A. Linde, and P. Biberfeld. 1995. A 
role for a new herpes virus (KSHV) in different forms of Kaposi’s sar-
coma. Nat. Med. 1:707–708. doi:10.1038/nm0795-707
Walsh, T., H. Shahin, T. Elkan-Miller, M.K. Lee, A.M. Thornton, W. 
Roeb, A. Abu Rayyan, S. Loulus, K.B. Avraham, M.C. King, and M. 
Kanaan. 2010. Whole exome sequencing and homozygosity mapping 
identify mutation in the cell polarity protein GPSM2 as the cause of 
nonsyndromic hearing loss DFNB82. Am. J. Hum. Genet. 87:90–94. 
doi:10.1016/j.ajhg.2010.05.010
Zurrida, S., R. Agresti, and G. Cefalo. 1994. Juvenile classic Kaposi’s sar-
coma: a report of two cases, one with family history. Pediatr. Hematol. 
Oncol. 11:409–416. doi:10.3109/08880019409140540